| Literature DB >> 35407538 |
Won Seob Lee1, Seong Oh Park2, Il-Kug Kim1.
Abstract
While the transverse rectus abdominis myocutaneous (TRAM) flap is a popular option for abdominal-based breast reconstruction, abdominal wall morbidities such as bulging or hernia remain a concern. Here, we introduced a surgical technique for reinforcing the abdominal wall using an onlay autograft obtained from discarded zone IV tissue following a primary closure. We compared abdominal wall morbidities between patients receiving an onlay graft and those receiving primary closure only. We retrospectively reviewed the medical charts of patients who underwent breast reconstruction using a TRAM flap between December 2018 and May 2021. Additionally, we assessed donor-site morbidities based on physical examination. Of the 79 patients included, 38 had received a dermal graft and 41 had not. Donor-site morbidities occurred in 10 (24.5%) and 1 (2.6%) patients, and bulging occurred in 8 (19.5%) and 1 (2.6%) patients in the primary closure and dermal autograft groups, respectively. A statistically significant difference in the incidence of bulging was observed between the groups (p = 0.030). In conclusion, the introduction of a dermal autograft after primary closure can successfully ameliorate morbidities at the TRAM flap site.Entities:
Keywords: abdominal hernia; breast reconstruction; complications; dermis graft; tissue donors
Year: 2022 PMID: 35407538 PMCID: PMC8999363 DOI: 10.3390/jcm11071929
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Onlay dermal autograft from discarded zone IV tissue in the TRAM flap: (A) Direct closure was performed on both sides of the fascia in a horizontal-mattress fashion following flap elevation. The dermal onlay graft harvested from the discarded flap was stretched over the fascia on which the direct closure was performed. (B) An incision was made on the dermis at the site of the umbilicus through which the umbilical stalk was passed.
Patients’ demographics.
| Primary Closure (%) | Dermal Autograft (%) |
| |
|---|---|---|---|
| No. | 41 | 38 | |
| Mean age ± SD | 48.5 ± 7.4 | 47.9 ± 7.5 | 0.759 |
| BMI ± SD | 23.2 ± 3.0 | 25 ± 3.3 | 0.011 † |
| Follow-up period ± SD | 1.24 ± 0.62 | 1.04 ± 0.37 | 0.084 |
| Smokers | 3 (7.3) | 2 (5.3) | 1.000 |
| Anticoagulant use | 1 (2.4) | 1 (2.6) | 1.000 |
| History of abdominal surgery | 4 (9.8) | 3 (7.9) | 1.000 |
| Chemotherapy | 10 (24.4) | 12 (31.6) | 0.616 |
| Radiotherapy | 5 (12.2) | 4 (10.5) | 1.000 |
| Comorbidity | |||
| Diabetes mellitus | 3 (7.3) | 5 (13.2) | 0.471 |
| Hypertension | 3 (7.3) | 7 (18.4) | 0.183 |
| Dyslipidemia | 2 (4.9) | 5 (13.2) | 0.252 |
BMI, body mass index; SD, standard deviation; N/A, not applicable. † p < 0.05.
Operative characteristics.
| Primary Closure (%) | Dermal Autograft (%) |
| |
|---|---|---|---|
| Time of reconstruction | 0.133 | ||
| Immediate | 27 (65.9) | 31 (81.6) | |
| Delayed | 14 (34.1) | 7 (18.4) | |
| Type of reconstruction | <0.05 † | ||
| Free TRAM | 26 (63.4) | 3 (7.9) | |
| Pedicled TRAM | 15 (36.6) | 35 (92.1) |
TRAM, transverse rectus abdominus myocutaneous. † p < 0.05.
Donor-site morbidities.
| Primary Closure (%) | Dermal Autograft (%) |
| |
|---|---|---|---|
| Donor Morbidity | |||
| Bulging | 8 (19.5) | 1 (2.6) | 0.030 † |
| Hernia | 0 (0.0) | 0 (0.0) | N/A |
| Fat necrosis | 1 (2.4) | 0 (0.0) | 1.000 |
| Seroma | 0 (0.0) | 0 (0.0) | N/A |
| Umbilicus necrosis | 1 (2.4) | 0 (0.0) | 1.000 |
| Wound dehiscence | 0 (0.0) | 0 (0.0) | N/A |
N/A, not applicable. † p < 0.05.
Figure 2Clinical image of a 50-year-old female patient taken 6 months after delayed breast reconstruction with a pedicled TRAM flap. Direct closure was performed on the donor's fascial defect. A distinct bulging at the site of the fascial defect was found during a physical examination.
Figure 3Surgical techniques used for the correction of abdominal bulging. (A) Plication of the abdominal fascia. (B) Onlay graft of acellular dermal matrix.